Back to Scanner
KALV
NASDAQRS 7Score 38KalVista Pharmaceuticals, Inc.
HealthcareBiotechnology$1.02B2 setups passing
$19.90
-1.0% ($0.19)
-6.6% from 52W High
P/E (TTM)
-6.00
Fwd P/E
—
PEG
—
Analyst Upside
+73.4%
EPS Growth
—
Gross Margin
68.7%
ROE
-444.4%
D/E
-104.83
Div Yield
0.0%
Avg Volume
910.8K
Price Chart
Key Levels
SMA 200
$14.30
SMA 50
$16.39
Price
$19.90
52W High
$21.31
Target
$34.50
Setup Radar
2/8 passing📈
CAN SLIMO'Neil
Near highs + RS ≥ 80
🎯
VCPMinervini
Within 25% high, RS ≥ 70, > 200 SMA
📊
Trend TemplateMinervini
> 50 & 200 SMA, RS ≥ 70, near high
🚀
Stage 2Weinstein
RS ≥ 60, > 200 SMA
📦
Darvas BoxDarvas
Near highs, > 200 SMA
⚡
Earnings MomentumGrowth
EPS growth ≥ 20%
🔍
PEG HunterLynch
PEG < 1.5, EPS growth ≥ 15%
🎪
Analyst UpsideConsensus
Target upside ≥ 15%, 1+ analyst